By John Burkhardt, Pfizer Groton Site Head
As the world increases our understanding of the importance and benefits of diversity in thought, I am proud and excited to announce that Pfizer has launched a new Research and Development (R&D) Rotational Program designed to provide young diverse talent exposure to different aspects of research and clinical development.
This program will give us the opportunity to bring in recent college graduates who identify as historically underrepresented in science, technology, engineering, and mathematics (STEM). The two-year program is designed to grow Pfizer’s pipeline of R&D talent and support our commitment to equity among rising leaders of the African American/Black and Latino/Hispanic communities.